This is information that seems unlikely. However, researchers have shown that resistant starches, contained among others in bananas, prevent certain cancers.
Thehave the power to prevent cancer? The results of a recent clinical trial, published in , might suggest. In fact, scientists have studied whether a daily intake of 30 grams of resistant starch — a type of starch that is not digested by — present in green bananas, or even the can prevent the appearance of certain .
This research was carried out on very specific patients, suffering fromof Lynch. This is a problem original which disrupts the repair mechanisms of the . As a result, people with Lynch syndrome have a higher risk of developing cancer at a young age than average. The attacks are diverse, but colorectal cancers are the most frequent, followed by those of the endometrium and . reduces their risk of developing, but for cancers that affect other parts of the body, scientists have not found a way to effective…until they got into resistant starches.
Bananas, the anti-cancer gesture for people with Lynch syndrome
The results of this clinical trial are only of interest in a very limited context. By no means do these results suggest that resistant starches prevent allin the general population. On the other hand, they provide interesting data on a possible means of preventing non-colorectal cancers in people with Lynch syndrome.
The 918 participants in this trial were separated into two groups: a group that consumed 30 g per day of resistant starch in powder form and a group that consumed a. The follow-up was done over the long term. If the patients in the “resistant starch” group took this supplement for four years, their state of health and the appearance of cancers were examined for almost ten years for the majority and up to twenty years for some of them. .
The results show that resistant starches have no effect on theof the in patients with Lynch syndrome, but on other cancers. The effect is particularly noticeable on cancers of the upper gastrointestinal tract. In the “resistant starch” group, 27 people developed non-colorectal cancer compared with 48 in the placebo group; more than two years after the start of the clinical trial.
The scientists conclude that resistant starches have a protective effect against non-colorectal cancers in people with Lynch syndrome, although they still note certain limits to their result. Indeed, their first hypothesis was that resistant starches actually have an effect on the prevention of, which they could not show here. The of Lynch syndrome in the general population is not known and the individual risk of each disease also depends on other factors such as age, gender or lifestyle.